Exploring the critical role of hormonal disorders in metabolic-associated steatotic liver disease (MASLD) pathogenesis and treatment.
Discover how IGFBP-1, a natural liver protein, shows promise in treating nonalcoholic fatty liver disease by reducing fat accumulation and inflammation.